Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers

NCT02886845 is registered in ClinicalTrials.gov with Song Hongping as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02886845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers
Lead sponsor
Song Hongping
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2016
Completion date
June 30, 2023
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rs185670819 and rs183489969